The constitutive activation of Jak2-V617F is mediated by a π stacking mechanism involving phenylalanines 595 and 617.
about
Janus kinase inhibitors: jackpot or potluck?Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617FStructure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinasesMolecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase.Identification of novel SAR properties of the Jak2 small molecule inhibitor G6: significance of the para-hydroxyl orientationAb initio modeling and experimental assessment of Janus Kinase 2 (JAK2) kinase-pseudokinase complex structure.ATP binding to the pseudokinase domain of JAK2 is critical for pathogenic activationMolecular insights into regulation of JAK2 in myeloproliferative neoplasmsUncoupling JAK2 V617F activation from cytokine-induced signalling by modulation of JH2 αC helix.A structure-function perspective of Jak2 mutations and implications for alternate drug design strategies: the road not taken.Activating Janus kinase pseudokinase domain mutations in myeloproliferative and other blood cancers.Molecular genetics of myelofibrosis and its associated disease phenotypes.Enhancing specificity in the Janus kinases: a study on the thienopyridine JAK2 selective mechanism combined molecular dynamics simulation.A shift in the salt bridge interaction of residues D620 and E621 mediates the constitutive activation of Jak2-H538Q/K539L.
P2860
Q27027230-AE655012-18C2-4DBF-9499-3129146361B5Q27670859-8F62CBD0-6984-48E4-A5E8-98C91597C1DFQ27679885-DFA071C2-6E95-4EDB-9931-3E063C9FD933Q30658298-DE8A3C43-AA69-4A23-9E48-FED5F93C0CF8Q34121282-72F121B7-FB16-4F2E-80A6-9F0E8657FDF4Q34671755-91381889-EDA6-47BC-B133-3D5778FF58E8Q35484880-BAE17B2F-0A68-42D2-BFBE-9C930DBC9EEEQ35661987-528CB05C-60B7-4888-B856-EAF37392B989Q36955078-DCA71ADA-D3FD-4FA1-9447-33618EC59D26Q37921836-545005AC-5410-4A00-8B47-2F85536CDBFAQ38122238-2804B8BE-1D8C-4D28-8438-109AD5F14504Q38208010-7BE52445-9D26-4824-9D27-9A2677726C09Q40188503-896CDAE6-B5D1-4BCA-BEE0-C57441B74525Q43760932-2950A310-212B-4466-A7CD-0CFE05C45AE1
P2860
The constitutive activation of Jak2-V617F is mediated by a π stacking mechanism involving phenylalanines 595 and 617.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The constitutive activation of ...... ng phenylalanines 595 and 617.
@ast
The constitutive activation of ...... ng phenylalanines 595 and 617.
@en
The constitutive activation of ...... ng phenylalanines 595 and 617.
@nl
type
label
The constitutive activation of ...... ng phenylalanines 595 and 617.
@ast
The constitutive activation of ...... ng phenylalanines 595 and 617.
@en
The constitutive activation of ...... ng phenylalanines 595 and 617.
@nl
prefLabel
The constitutive activation of ...... ng phenylalanines 595 and 617.
@ast
The constitutive activation of ...... ng phenylalanines 595 and 617.
@en
The constitutive activation of ...... ng phenylalanines 595 and 617.
@nl
P2860
P356
P1433
P1476
The constitutive activation of ...... ing phenylalanines 595 and 617
@en
P2093
Kavitha Gnanasambandan
Peter P Sayeski
P2860
P304
P356
10.1021/BI1014858
P407
P577
2010-10-29T00:00:00Z